Harold H. Shlevin, Chief Operating Officer at GALECTIN THERAPEUTICS INC (GALT), sold 41,662 shares at $5.16 ($215K) on 2018-06-05, disclosed to the SEC on 2018-06-06.
Open-market sale of $215k GALT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.15 | 10,907 | $56K | 26.2% |
| 2 | $5.15 | 10,907 | $56K | 26.2% |
| 3 | $5.16 | 9,924 | $51K | 23.8% |
| 4 | $5.16 | 9,924 | $51K | 23.8% |
| Total | $5.15 avg | 41,662 | $215K | 100% |
| Filing → |
| GALT | SELL | 2025-12-16 | $354K | — | Filing → |
| GALT | SELL | 2025-12-10 | $1.3M | — | Filing → |
| GALT | BUY | 2024-12-31 | $8K | — | Filing → |